28Jun
[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action
Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By:
Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/
Related
In 2012, the Equal Employment Opportunity Commission issued enforcement guidance on employers’ use ...
Read More >
Seyfarth Synopsis: As we reported here, the CBD (cannabidiol) craze is sweeping the nation. By 2022,...
Read More >
The U.S. Court of Appeals for the Federal Circuit, in U.S. Army Corps of Engineers v. John C. Grimbe...
Read More >
The Federal Trade Commission has announced revised thresholds for interlocking directorates required...
Read More >
We are barely two months into the new year and already there are significant updates to the 2020 Sup...
Read More >
Hot on the heels of the £20 million fine issued to British Airways, the Information Commissioner’s ...
Read More >